180 related articles for article (PubMed ID: 16449526)
1. Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.
Reschly EJ; Spaulding C; Vilimas T; Graham WV; Brumbaugh RL; Aifantis I; Pear WS; Kee BL
Blood; 2006 May; 107(10):4115-21. PubMed ID: 16449526
[TBL] [Abstract][Full Text] [Related]
2. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
3. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice.
Feldman BJ; Hampton T; Cleary ML
Blood; 2000 Sep; 96(5):1906-13. PubMed ID: 10961893
[TBL] [Abstract][Full Text] [Related]
4. Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.
Spaulding C; Reschly EJ; Zagort DE; Yashiro-Ohtani Y; Beverly LJ; Capobianco A; Pear WS; Kee BL
Blood; 2007 Oct; 110(7):2650-8. PubMed ID: 17585052
[TBL] [Abstract][Full Text] [Related]
5. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma.
Talora C; Campese AF; Bellavia D; Pascucci M; Checquolo S; Groppioni M; Frati L; von Boehmer H; Gulino A; Screpanti I
EMBO Rep; 2003 Nov; 4(11):1067-72. PubMed ID: 14566327
[TBL] [Abstract][Full Text] [Related]
6. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.
Yashiro-Ohtani Y; He Y; Ohtani T; Jones ME; Shestova O; Xu L; Fang TC; Chiang MY; Intlekofer AM; Blacklow SC; Zhuang Y; Pear WS
Genes Dev; 2009 Jul; 23(14):1665-76. PubMed ID: 19605688
[TBL] [Abstract][Full Text] [Related]
7. Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas.
Xu W; Kee BL
Blood; 2007 May; 109(10):4406-14. PubMed ID: 17272506
[TBL] [Abstract][Full Text] [Related]
8. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
9. Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.
Mantha S; Ward M; McCafferty J; Herron A; Palomero T; Ferrando A; Bank A; Richardson C
Leuk Res; 2007 Mar; 31(3):321-7. PubMed ID: 16870249
[TBL] [Abstract][Full Text] [Related]
10. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
Mikkers H; Allen J; Berns A
Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
[TBL] [Abstract][Full Text] [Related]
11. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
12. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
[TBL] [Abstract][Full Text] [Related]
13. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
[TBL] [Abstract][Full Text] [Related]
15. NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.
Dubois S; Feigenbaum L; Waldmann TA; Müller JR
Cell Immunol; 2020 Jun; 352():104081. PubMed ID: 32143838
[TBL] [Abstract][Full Text] [Related]
16. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma.
Lin YW; Nichols RA; Letterio JJ; Aplan PD
Blood; 2006 Mar; 107(6):2540-3. PubMed ID: 16282337
[TBL] [Abstract][Full Text] [Related]
17. p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
Fasseu M; Aplan PD; Chopin M; Boissel N; Bories JC; Soulier J; von Boehmer H; Sigaux F; Regnault A
Blood; 2007 Oct; 110(7):2610-9. PubMed ID: 17507663
[TBL] [Abstract][Full Text] [Related]
18. Activating Notch1 mutations in mouse models of T-ALL.
O'Neil J; Calvo J; McKenna K; Krishnamoorthy V; Aster JC; Bassing CH; Alt FW; Kelliher M; Look AT
Blood; 2006 Jan; 107(2):781-5. PubMed ID: 16166587
[TBL] [Abstract][Full Text] [Related]
19. Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.
Engel I; Murre C
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11322-7. PubMed ID: 12172006
[TBL] [Abstract][Full Text] [Related]
20. Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling.
Campese AF; Garbe AI; Zhang F; Grassi F; Screpanti I; von Boehmer H
Blood; 2006 Jul; 108(1):305-10. PubMed ID: 16507772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
